Lionel Hutz on Liquidia's patent battle $LQDA - a podcast by Andrew Walker

from 2022-12-19T13:53:01

:: ::

Lionel Hutz discusses his thesis for Liquidia (LQDA) and why the thinks they are likely to win their patent battle against United Therapeutics (UTHR).


Lionel's LQDA write up: https://lionelhutz.substack.com/p/waiting-with-bated-breath-for-liquidia


Chapters 



  • 0:00 Intro 

  • 2:50 LQDA overview 

  • 8:05 Diving into the patent background 

  • 16:10 Breaking down the conflicting rulings on the '793 patent 

  • 19:55 Why the PTAB ruling is the most important for '793 

  • 21:55 What's so unique about the judge's ruling on '793 

  • 28:30 Why PTAB ruled the '793 patent invalid 

  • 37:40 LQDA's primary argument for invalidating '793 

  • 43:30 Discussing the expert reports around the '793 patent 

  • 53:30 Timeline to monetization and why delaying LQDA is so important for UTHR 

  • 59:00 LQDA's upside if they win 

  • 1:13:00 LQDA's cash runway

Further episodes of Yet Another Value Podcast

Further podcasts by Andrew Walker

Website of Andrew Walker